KBC Securities - MDXHEALTH (MDXH) mdxhealth FIRST LOOK: 3Q24 results come with upgraded FY24 guidance

Report

KBC Securities

Jacob Mekhael

mdxhealth FIRST LOOK: 3Q24 results come with upgraded FY24 guidance

mdxhealth reported 3Q24 revenue growth of 21% y/y, while management upgraded FY24 guidance to $ 87-89m (previously $ 85-87m) reflecting increased confidence in utilisation from healthcare providers. The goal to reach positive adjusted EBITDA by 1H25 remains on track, and now starts to come into view, while management guided for 20% topline growth for FY25. We reiterate our $ 4.2 TP and Buy rating.

07/11/2024 1 EN

Underlying

MDXHEALTH

See profile

BE0974461940 Euronext Brussels Belgium

Provider

KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

See profile

Analysts

Jacob Mekhael

Other Reports on these Companies

KBC Securities

Morning Notes : AALB NA, ADYEN NA, CPINV BB, CMBT BB, GBLB BB, MDXH BB, TESB BB, ALFEN NA

: AALB NA, ADYEN NA, CPINV BB, CMBT BB, GBLB BB, MDXH BB, TESB BB, ALFEN NA

11h / 13m 11h / 13m 1 EN

GlobeNewsWire

MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2024

MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2024 Tissue-based test volumes increase by 36%, liquid-based test volumes by 24% Company raises 2024 revenue guidance to $87-89 million, representing 25% growth Pro-forma cash of $53.5 million Conference call and webcast today at 4:30pm ET IRVINE, CA – November 6, 2024 () – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leading precision diagnostics company, today announced its financial results for the third quarter and nine-month period ended September 30, 2024. Michael K. McGar...

22h / 7m 22h / 7m 1 EN

Aalberts 10m24 trading update

Aalberts just issued a trading update on the first ten months of the year. As usual the update was brief, mainly qualitative and only commenting on segmental organic growth rates. Overall organic growth over 10m24 landed at ‘-2.9%' a slight improvement compared to the ‘-3.9%' reported at 1H24. As last year, the added value margin was labelled ‘good'. In an environment of negative topline growth, company is working hard on its cost base to sustain margins. A disposal occurred in US Piping and restructuring efforts were intensified. Over 1H24 an estimated €10m restructuring costs were taken. Now...

10h / 28m 10h / 28m 1 EN

Thomas Couvreur

Thomas Couvreur

GBL 3Q24: NAV Up 3.6% To €118 & Capital Markets Day Today

As of 3Q-end, GBL's NAVps stood at €117.99, up 3.6% compared to 1H FY24 (€113.9). On a YTD basis, GBL's disposals of listed assets has helped crystallise capital gains of €1.1b (€630.0m during 9M'24 and €422.0m coming from forward sales that matured on 24th Oct'24). Notably, the stake in Adidas has been cut in half from 7.6% to 3.51%. GBL continues to have an attractive overall liquidity profile of €4.3b, which should be sufficient to seize an opportunities over the short to medium-term. We note that shares of Pernod Ricard (approx. 13.0% of NAVps) have declined almost 30.0% YTD and has put do...

10h / 51m 10h / 51m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

mdxhealth FIRST LOOK: 3Q24 results come with upgraded FY24 guidance

We are a financial services provider for several types of professional clients, each with distinct needs.

Morning Notes : AALB NA, ADYEN NA, CPINV BB, CMBT BB, GBLB BB, MDXH BB, TESB BB, ALFEN NA

MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2024

Aalberts 10m24 trading update

GBL 3Q24: NAV Up 3.6% To €118 & Capital Markets Day Today

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe